The Relationship between Sleep Disturbances and Glycemic Control in Children with Type 1 Diabetes
DOI:
https://doi.org/10.54112/bcsrj.v6i3.1621Keywords:
Adolescent, Blood Glucose, Child, Diabetes Mellitus, Sleep Wake DisordersAbstract
Children with Type 1 Diabetes Mellitus (T1DM) require careful glycemic management to prevent both acute and long-term complications. Objectives: To evaluate the association between sleep disturbances and glycemic control in children and adolescents with T1DM and to determine whether sleep quality independently predicts HbA1c levels. Methods: This cross-sectional study was conducted at the University of Lahore Teaching Hospital from September 2024 to February 2025. A total of 185 children and adolescents, aged 6 to 18 years, diagnosed with T1DM for at least 12 months, were recruited for the study. Demographic information, such as age, gender, and diabetes duration, was recorded. Medical data on insulin regimen (MDI or pump), CGM use, and physical activity levels were gathered through parent review of medical records. Results: Sleep disturbances were highly prevalent, with 72% of participants scoring above the clinical threshold on the CSHQ. A moderate positive correlation was observed between sleep disturbance scores and HbA1c (r = 0.41, p < 0.001). Regression analysis confirmed that sleep disturbance score was an independent predictor of HbA1c (β = 0.38, p < 0.001), even after adjusting for confounders. Additionally, children with shorter sleep durations (<7 hours) had significantly higher HbA1c levels (mean: 9.1%) compared to those with ≥9 hours of sleep (mean: 7.7%). Conclusion: It is concluded that sleep disturbances are common in children with T1DM and are significantly associated with poorer glycemic control. Sleep quality should be routinely evaluated as part of comprehensive diabetes management. Targeted interventions to improve sleep may offer a low-cost, behavioral strategy to support better metabolic outcomes in this population.
Downloads
References
Berk E, ÇELIK N. Sleep quality and glycemic control in children and adolescents with type 1 diabetes mellitus. European Review for Medical & Pharmacological Sciences. 2023;27(10).
Adler A, Gavan MY, Tauman R, Phillip M, Shalitin S. Do children, adolescents, and young adults with type 1 diabetes have increased prevalence of sleep disorders? Pediatric diabetes. 2017;18(6):450-8.
Pantanetti P, Biondini F, Mancin S, Sguanci M, Masini A, Panella M, et al. Sleep Quality and Glycemic Control in Type 1 Diabetes: A Retrospective Cohort Study Using Advanced Technological Devices. Diabetology. 2025;6(3):21.
Magliano DJ, Boyko EJ. IDF diabetes atlas. 2022.
Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nature Reviews Cardiology. 2023;20(10):685-95.
Ziady HH, El-Zeiny NAE-m, Fetohy EM, Hewi SAH, Hagras EMA. Assessment of diabetes health literacy and its predictors among diabetic older adults attending geriatric clubs, 2024. Alexandria Journal of Medicine. 2025;61(1):1-10.
IHME. Global Burden of Disease Collaborative Network. Institute for Health Metrics and Evaluation (IHME), Seattle, United States; 2020.
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203-34.
Petrelli F, Cangelosi G, Scuri S, Thu NCT, Debernardi G, Benni A, et al. Food knowledge of patients at the first access to a Diabetology center: Food knowledge of patients at the first access to a Diabetology center. Acta Biomedica Atenei Parmensis. 2020;91(3-S):160-4.
Cangelosi G, Grappasonni I, Nguyen CTT, Acito M, Pantanetti P, Benni A, et al. Mediterranean Diet (MedDiet) and Lifestyle Medicine (LM) for support and care of patients with type II diabetes in the COVID-19 era: a cross-observational study. Acta Bio-medica: Atenei Parmensis. 2023;94(S3):e2023189-e.
Ferrari A, Santomauro D, Aali A, Abate Y, Abbafati C, Abbastabar H. GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133-61.
Cangelosi G, Acito M, Grappasonni I, Nguyen CTT, Tesauro M, Pantanetti P, et al. Yoga or Mindfulness on Diabetes: Scoping Review for Theoretical Experimental Framework. Ann Ig. 2024;36:153-68.
Jacobsen LM, Sherr JL, Considine E, Chen A, Peeling SM, Hulsmans M, et al. Utility and precision evidence of technology in treating type 1 diabetes: a systematic review. Communications medicine. 2023;3(1):132.
Tejera-Pérez C, Chico A, Azriel-Mira S, Lardiés-Sánchez B, Gomez-Peralta F. Connected insulin pens and caps: an expert’s recommendation from the area of diabetes of the Spanish Endocrinology and Nutrition Society (SEEN). Diabetes Therapy. 2023;14(7):1077-91.
Jaser SS, Foster NC, Nelson BA, Kittelsrud JM, DiMeglio LA, Quinn M, et al. Sleep in children with type 1 diabetes and their parents in the T1D Exchange. Sleep medicine. 2017;39:108-15.
Pantanetti P, Cangelosi G, Morales Palomares S, Ferrara G, Biondini F, Mancin S, et al. Real-World Life Analysis of a Continuous Glucose Monitoring and Smart Insulin Pen System in Type 1 Diabetes: A Cohort Study. Diabetology. 2025;6(1):7.
Griggs S, Grey M, Strohl KP, Crawford SL, Margevicius S, Kashyap SR, et al. Variations in sleep characteristics and glucose regulation in young adults with type 1 diabetes. The Journal of Clinical Endocrinology & Metabolism. 2022;107(3):e1085-e95.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Sana Sarfaraz, Bakhtawar Tahir, Tahir Humaira, Hasnain Faeza

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.